PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11266081-6	2001	For the proband homozygous for the human FMO3 gene deletion, it is predicted that in addition to loss of monooxygenase function for human FMO3 substrates, such as TMA and other amines, the proband will exhibit decreased tolerance of biogenic amines, both medicinal and those found in foods.	Amines	177-183	flavin containing dimethylaniline monoxygenase 3	Homo sapiens	41-45	
11266081-6	2001	For the proband homozygous for the human FMO3 gene deletion, it is predicted that in addition to loss of monooxygenase function for human FMO3 substrates, such as TMA and other amines, the proband will exhibit decreased tolerance of biogenic amines, both medicinal and those found in foods.	Amines	177-183	flavin containing dimethylaniline monoxygenase 3	Homo sapiens	138-142	
11266081-6	2001	For the proband homozygous for the human FMO3 gene deletion, it is predicted that in addition to loss of monooxygenase function for human FMO3 substrates, such as TMA and other amines, the proband will exhibit decreased tolerance of biogenic amines, both medicinal and those found in foods.	Amines	242-248	flavin containing dimethylaniline monoxygenase 3	Homo sapiens	41-45	
11266081-6	2001	For the proband homozygous for the human FMO3 gene deletion, it is predicted that in addition to loss of monooxygenase function for human FMO3 substrates, such as TMA and other amines, the proband will exhibit decreased tolerance of biogenic amines, both medicinal and those found in foods.	Amines	242-248	flavin containing dimethylaniline monoxygenase 3	Homo sapiens	138-142